Three major oncology organizations recommend that CEA be measured in patients with nonmetastatic colorectal cancer prior to surgical resection. In the current analysis, patients with a normal ...
Background: The usefulness of tumor markers in NSCLC is not well defined. High levels of CEA are considered a negative prognostic factor in early-stages NSCLC but its role in advanced disease is yet ...
Patterns of maintenance treatment (Tx) following first-line bevacizumab (bev) plus chemotherapy (CT) for metastatic colorectal cancer (mCRC): Results from a large German community-based cohort study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results